We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 7,612 results
  1. Estrogen-immuno-neuromodulation disorders in menopausal depression

    A significant decrease in estrogen levels puts menopausal women at high risk for major depression, which remains difficult to cure despite its...

    Yuling Zhang, **ying Tan, Chaozhi Tang in Journal of Neuroinflammation
    Article Open access 19 June 2024
  2. Estrogen signaling via estrogen receptor alpha and its implications for neurodegeneration associated with Alzheimer’s disease in aging women

    Estrogen receptor alpha (ERα) is a transcription factor activated by estrogenic hormones to regulate gene expression in certain organs, including the...

    Angeles C. Tecalco-Cruz, Lilia López-Canovas, Elisa Azuara-Liceaga in Metabolic Brain Disease
    Article 14 January 2023
  3. The Possible Role of Brain-derived Neurotrophic Factor in Epilepsy

    Epilepsy is a neurological disease characterized by repeated seizures. Despite of that the brain-derived neurotrophic factor (BDNF) is implicated in...

    Raed AlRuwaili, Hayder M. Al-kuraishy, ... Gaber El-Saber Batiha in Neurochemical Research
    Article Open access 25 November 2023
  4. The Triad of Estrogen, Estrogen Receptors, and Colon Cancer

    Colon cancer is one of the common malignancies in the developed world irrespective of the sexes. The incidence of colon cancer is increasing leaps...
    K. R. Sumalatha, Syamala Soumyakrishnan, M. Sreepriya in Colon Cancer Diagnosis and Therapy Vol. 3
    Chapter 2022
  5. Role of Brain-Derived Neurotrophic Factor in Anxiety or Depression After Percutaneous Coronary Intervention

    Anxiety or depression after percutaneous coronary intervention (PCI) is one of the key clinical problems in cardiology that need to be solved...

    Bo Ning, Teng Ge, ... Mingjun Zhao in Molecular Neurobiology
    Article 10 November 2023
  6. Selective Activation of G Protein–Coupled Estrogen Receptor 1 (GPER1) Reduces ER Stress and Pyroptosis via AMPK Signaling Pathway in Experimental Subarachnoid Hemorrhage

    Neuroinflammation is a critical pathogenic event following hemorrhagic stroke. Endoplasmic reticulum (ER) stress–induced apoptosis and...

    Yidan Liang, Wenqiao Fu, ... Yongbing Deng in Molecular Neurobiology
    Article 27 June 2024
  7. Molecular Mechanisms of Exercise in Brain Disorders: a Focus on the Function of Brain-Derived Neurotrophic Factor–a Narrative Review

    The natural aging process as well as many age-related diseases is associated with impaired metabolic adaptation and declined ability to cope with...

    Zeinab Rezaee, Sayed Mohammad Marandi, Hojjatallah Alaei in Neurotoxicity Research
    Article 03 June 2022
  8. The Interaction Between NF-κB and Estrogen in Alzheimer’s Disease

    Post-menopausal women are at a higher risk of develo** Alzheimer’s disease (AD) than males. The higher rates of AD in women are associated with the...

    Pranav Mishra, Don A. Davies, Benedict C. Albensi in Molecular Neurobiology
    Article 13 December 2022
  9. Nuclear receptor ligand screening in an iPSC-derived in vitro blood–brain barrier model identifies new contributors to leptin transport

    Background

    The hormone leptin exerts its function in the brain to reduce food intake and increase energy expenditure to prevent obesity. However, most...

    Yajuan Shi, Hyosung Kim, ... Ethan S. Lippmann in Fluids and Barriers of the CNS
    Article Open access 21 September 2022
  10. Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential

    Synaptic abnormalities are a cardinal feature of Alzheimer’s disease (AD) that are known to arise as the disease progresses. A growing body of...

    Lina Gao, Yun Zhang, ... Weihong Song in Translational Neurodegeneration
    Article Open access 28 January 2022
  11. Role of KCC2 in the Regulation of Brain-Derived Neurotrophic Factor on Ethanol Consumption in Rats

    Alcohol use disorder (AUD) is a common and complex disorder resulting from repetitive alcohol drinking. The mesocorticolimbic dopamine (DA) system,...

    Hongyan Zhang, Lulu Xu, ... Yanzhong Guan in Molecular Neurobiology
    Article 19 November 2022
  12. Sex differences of signal complexity at resting-state functional magnetic resonance imaging and their associations with the estrogen-signaling pathway in the brain

    Sex differences in the brain have been widely reported and may hold the key to elucidating sex differences in many medical conditions and drug...

    Cheng-li Zhao, Wenjie Hou, ... Qiang Luo in Cognitive Neurodynamics
    Article 23 March 2023
  13. Redox Regulation of Estrogen Signaling in Human Breast Cancer

    Estrogen and oxidative stress are interconnected in a very delicate fashion, leading to redox regulation of estrogen and its regulatory molecules. On...
    Reference work entry 2022
  14. Sex and the Estrous-Cycle Phase Influence the Expression of G Protein-Coupled Estrogen Receptor 1 (GPER) in Schizophrenia: Translational Evidence for a New Target

    Schizophrenia is a mental disorder with sex bias in disease onset and symptom severity. Recently, it was observed that females present more severe...

    Francisco Eliclécio Rodrigues da Silva, Rafaela Carneiro Cordeiro, ... Danielle S. Macedo in Molecular Neurobiology
    Article 14 March 2023
  15. Involvement of the G-Protein-Coupled Estrogen Receptor-1 (GPER) Signaling Pathway in Neurodegenerative Disorders: A Review

    The G-protein-coupled estrogen receptor-1 (GPER) is an extranuclear estrogen receptor that regulates the expression of several downstream signaling...

    Shubham Upadhayay, Rishav Gupta, ... Puneet Kumar in Cellular and Molecular Neurobiology
    Article 28 October 2022
  16. Estrogen Neuroprotective Activity After Stroke and Spinal Cord Injury

    Morphological studies have revealed that in mammals the brain is a sexually dimorphic organ and estrogenEstrogen are responsible for brain...
    Chapter 2023
  17. Nanomedicine in therapeutic warfront against estrogen receptor–positive breast cancer

    Breast cancer (BC) is the most frequently diagnosed malignancy in women worldwide. Almost 70–80% of cases of BC are curable at the early...

    Mayur Aalhate, Srushti Mahajan, ... Pankaj Kumar Singh in Drug Delivery and Translational Research
    Article 16 February 2023
  18. Cannabinoids in traumatic brain injury and related neuropathologies: preclinical and clinical research on endogenous, plant-derived, and synthetic compounds

    Traumatic brain injury is common, and often results in debilitating consequences. Even mild traumatic brain injury leaves approximately 20% of...

    Brittney R. Lins, Chidozie C. Anyaegbu, ... Melinda Fitzgerald in Journal of Neuroinflammation
    Article Open access 19 March 2023
  19. Tamoxifen suppresses brain metastasis of estrogen receptor-deficient breast cancer by skewing microglia polarization and enhancing their immune functions

    Background

    Brain metastasis of breast cancer exhibits exceedingly poor prognosis, and both triple negative (TN) and Her2 + subtypes have the highest...

    Shih-Ying Wu, Sambad Sharma, ... Kounosuke Watabe in Breast Cancer Research
    Article Open access 18 March 2021
  20. Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer

    The human epidermal growth factor receptor 2 (HER2) is overexpressed in 13–22% of breast cancers (BC). Approximately 60–70% of HER2+ BC co-express...

    Mark Pegram, Christian Jackisch, Stephen R. D. Johnston in npj Breast Cancer
    Article Open access 31 May 2023
Did you find what you were looking for? Share feedback.